A large number of different mutations in the factor VIII (F8) gene have been identified as a cause of haemophilia A. This compilation lists known single base-pair substitutions, deletions and insertions in the F8 gene and reviews the status of the inversional events which account for a substantial proportion of mutations causing severe haemophilia A.
INTRODUCTION
Haemophilia A is an X-linked bleeding disorder affecting approximately 1 in 5000 males (reviewed by Green et al. 1991; Tuddenham and Cooper 1994; Hoyer 1994) . It is caused by deleterious mutations in the factor VIII (F8) gene leading to deficiency of factor VIII, a co-factor for the activation of factor X by factor IXa. The F8 gene comprises 26 exons spanning 186kb DNA (Gitschier et al. 1984 ; Toole et al. 1984) and encodes a 9kb mRNA.
A database of mutations in the F8 gene, including single basepair substitutions, deletions, insertions and rearrangements, was first published by Tuddenham et al. (1991) . We present here an updated list of F8 gene lesions. The major advances in our understanding of the molecular biology and genetics of haemophilia A are presented.
Inversions
The single most important advance in the last 3 years has been the elucidation of the molecular basis of the defects in about half of all patients with severe haemophilia A. Until recently, no mutations could be found in either the coding region or the splice junctions of the F8 gene in -4 0 % of patients with the severe form of the disease (Higuchi et al. 1991b ). The elucidation of this enigma came with the key finding that the screening of F8 cDNA fragments for mutations was hampered by the impossibility of performing PCR amplification across the exon 22/23 boundary in these patients (Naylor etal. 1992; 1993b) . This was suggestive of a defect in intron 22 which is, at 32kb, the largest intron in the F8 gene. A CpG island located within this intron, ~ 10kb 3' to exon 22, is thought to act as a bidirectional promoter for two transcribed genes, termed F8A and F8B (Levinson et al. 1990; . The F8A gene lacks introns and is transcribed in the opposite direction to the F8 gene. Two additional homologues of the F8A gene (termed the A genes), which are also transcribed, exist ~ 500kb upstream of the F8 gene near the telomere (Levinson et al. 1990; . These genes are transcribed in the opposite direction to F8A.
It is now known that homologous intra-chromosomal recombination occurs between one or other of the upstream A genes and the F8A gene, generating inversions of the intervening F8 gene sequence. Such inversions, which occur in ~40% of severe haemophiliacs, result in the separation of exons 1-22 from exons 23-26 by some 200-500kb DNA (Lakich et al. 1993 ; Naylor et al. 1993b ). Millar et al. (1994) screened a total of 164 unrelated patients with severe haemophilia A for partial inversions of the FS gene. Inversions were found in 69 (42%) patients; most (90%) involved the distal rather than the proximal A gene. This unique mutational mechanism is therefore estimated to occur with a frequency of 7.2 X 10~6 per gene per gamete per generation. Although two patients with an inversion possessed inhibitors (antibodies) against factor VHI, possession of inhibitors did not appear to be associated disproportionately with inversiontype mutations (Millar et al. 1994 ).
*To whom correspondence should be addressed Goodeve et al. (1994) reported an inversion frequency of 48% in their study of 23 patients. Collins et al. (1994) and Ljung (1994) have reported inversion frequencies of 47% (85 patients) and 46% (41 patients) respectively. The frequencies of the proximal inversion of these three studies were 9%, 20% and 21 % of the total number of inversions. Tizzanoe?a/. (1994) reported an inversion frequency of 39% (92 patients); 36% of their patients with inversions developed inhibitor, a much higher proportion than that reported by Millar et al. (1994) .
Point mutations
A total of 174 different single base-pair substitutions are listed in Table 1 . Of these, 138 are missense mutations whilst 24 are nonsense mutations. An additional 12 mutations are thought to abolish correct mRNA splicing, either by removing a donor splice site (5) or an acceptor splice site (5) or possibly by activating a cryptic splice site (2) . Some 25% of these single base-pair substitutions occur within CpG dinucleotides and are compatible with a mechanism of methylation-mediated deamination (i.e. C -T or G-A). Consistent with this dinucleotide being a hotspot for mutation (Cooper and Krawczak, 1993) , examples of multiple mutation at CpG sites are frequent in the database.
Some 31 patients in the database possess inhibitors to exogenously given factor VIII; 27 of these (87%) possess nonsense mutations whereas 4 (13%) possess missense mutations. Intriguingly, two of the missense mutations (Arg 2209-Gin and Trp 2229-Cys) result in mild/moderate haemophilia A ( 3 -7 % FVIH:C). Inhibitors ca therefore still occur in patients with residual circulating factor VIII.
The clinical phenotype exhibited by haemophilia A patients with the same point mutation is not always the same. Examples of this phenomenon are to be found at codons 22, 162, 295, 326, 390, 412, 473, 479, 593, 704, 1680, 1689, 1922, 1941, 1997, 2150 , 2159, 2209, 2304 and 2307. Among possible explanations are the influence of coinherited mutations/variants/polymorphisms, inter-laboratory differences in either assas or clinical assessment or the epistatic effects of other loci. Berg et al. (1994) have described a probable epistatic effect in a case of mild/moderate haemophilia A; coinheritance of both factor XI deficiency and haemophilia A was associated with a bleeding tendency that was more severe than that associated with either deficiency alone.
Deletions
A. Gross gene deletions. Some 78 different gross deletions of the F8 gene have been reported in the literature (Table 2A) . These range in size from 2 to > 210kb. However, only a minority have been well mapped and only a few have had their breakpoints characterized. All but three are associated with a severe clinical phenotype. A substantial proportion (33%) are associated with the development of inhibitors.
B. Small deletions.
A total of 39 different micro-deletions of the F8 gene have been reported (Table 2B ). These range in size from 1 to 23bp. A hotspot for deletions is evident between codons 339 and 341. The three different deletions reported at this location are consistent with a slipped .mispairing mechanism; they span a double direct repeat (AATAATGAAGAA) sequence which matches the deletion hotspot consensus sequence of Cooper and Krawczak (1993) . None of these patients is known to possess an inhibitor.
Insertions
No further examples of LINE element insertion into the F8 gene (Kazazian et al. 1988 ) have been reported (Table 3) . Dombroski et al. (1991) showed that the LINE element originally found in patient JH27 is an exact but truncated copy of a full-length LINE element found at chromosome 22qll.l-qll.2. The latter progenitor element (LI .2B) is one of four LINE elements at this location and has been designated LRE1 (LI retrotransposable element 1). It appears to have occupied this position for at least 6 million years.
A total of 10 short insertions in the F8 gene have been reported (Table 3) ; most involve the insertion of a single base-pair; often an A within a stretch of A residues. The lObp insertion is a tandem duplication of existing sequence. The lbp insertion at codon 1439 occurs in the same position as a lbp deletion, within a stretch of 8A residues. Haldane (1935) demonstrated that for any X-linked lethal disorder, assuming the mutation rate in males and females to be equal, the proportion of mutations occurring de novo will be one third. A lower proportion will, however, be found if the mutation rate is higher in males than in females or if the fitness of carrier females is somehow increased. Based upon the observed rarity of sporadic cases, Haldane (1947) concluded that the mutation rate in males could be as much as 10-fold higher than in females. The accuracy of Haldane's method is however, influenced markedly by reproductive fitness. Oldenburg et al. (1993) attempted to estimate the sex ratio of mutation frequencies when reproductive fitness was set at either 0.3 or 0.5. Haldane's approach yielded a male:female mutation ratio of 5.37 (95% confidence limits 2.2-13.0). Use of the equilibrium-independent indirect method of Rosendaal et al. (1990) gave a male: female mutation ratio of 3.4 (95% confidence limits); 1.2-8.8). Oldenburg et al. (1993) performed carrier detection analysis in 119 families with haemophilia A by RFLP analysis or by direct detection of the pathological lesion. Data on the mutational origin allowed direct estimation of the male:female mutation ratio as 15:1. These studies therefore point to a significantly higher mutation frequency in males than in females.
Estimation of the sex ratio of mutation frequencies
Further characterization of the F8 gene A considerable number of repetitive sequence elements have been located in the F8 gene (Millar et al. 1993) ; some 30 Alu sequences are present in a total of 11 introns whilst three partial LINE elements are located within introns 13, 22 and 25. Lynch et al. (1993) have reported evidence that a 1.2kb segment of the F8 cDNA (spanning the A2 and A3 domains) acts as an inhibitor of mRNA accumulation and protein synthesis.
Indirect diagnosis of haemophilia A by linkage analysis
Although direct mutation analysis is now the method of choice for providing genetic counselling, carrier determination and antenatal diagnosis of haemophilia A, indirect diagnosis will continue to be used for various reasons. Firstly, only a minority of haemophilia treatment centres will be able to complete the mutation screening of their haemophilia A patients in the short term. Secondly, even if mutation screening can be performed, this is very time consuming as compared to linkage analysis. Moreover, many women at risk present only once they are pregnant, thus requiring urgent evaluation, and a high proportion of these will be from families where the mutation has not yet been determined. Finally, in many families, all affected males have already died from AIDS or other complications of haemophilia. Although the prevalent inversion mutation can be detected in heterozygotes, other mutations, especially gross deletions would not be readily detectable in a surviving carrier daughter for example.
Intronic polymorphisms therefore continue to represent valuable genetic markers for linkage studies. Such markers have recently been reviewed, and methods of analysis summarised, in a joint publication of the World Health Organization and the World Federation of Haemophilia (Peake et al. 1993 ). Reviews by Broecker-Vriends et al. (1992) and Sommer (1987) , may also be consulted. The most important recent advance in this area has been the discovery of two hypervariable dinucleotide tandem repeats in introns 13 and 22 of the F8 gene (Lalloz et al. 1991) . These can be analysed simultaneously (Lalloz et al. 1994 ) and can be determined rapidly and conveniently by automated laser scanning equipment (Schwaab etal. 1994 ). Up to 90% of females are informative (i.e. heterozygous) for at least one of the available intragenic markers. If other methods fail, antenatal diagnosis can be provided by fetal blood sampling at 18 weeks gestation. Preimplantation sex selection for female embryos has been successfully performed by biopsy of embryos at the 6 cell stage (Handyside et al. 1989 ). In principle, this could be applied to prevent Haemophilia A.
Mutation screening methods
The rapid increase in size of this database is due to the industry of many workers using the three rapid sensitive DNA screening methods that have been developed since 1987, all based on the polymerase chain reaction. These are the denaturing gradient gel electrophoresis (Fodde and Losekoot 1994), the chemical cleavage method (Cotton et al. 1988 ) and single stranded conformational polymorphism analysis (Hayashi and Yandell 1993) . Various advantages and drawbacks of each method in terms of sensitivity, technical difficulty and reagent hazard can be debated and will determine local choice. Detailed protocols are given in Michaelides et al. (1994) .
All three methods have been successfully applied to the F8 gene by at least one group e.g. DGGE, Higuchi et al. (1991a,b) ; chemical cleavage, Naylor et al. (1992) and SSCP, Lin et al. (1993) . These papers should be consulted for details of oligonucleotide primers required for the PCR amplification of individual exons of the F8 gene, or, in the case of Naylor et al. (1992) , the isolation and reverse transcription of ectopic mRNA transcripts from peripheral blood lymphocytes, and subsequent PCR amplification. This latter strategy has the added advantage of allowing the detection of missplicing events. Ann 
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